Tangible Shareholders Equity (Annual)

Tangible Shareholders Equity: The value shareholders equity less intangible assets.

Myriad Genetics, Inc. (MYGN) had Tangible Shareholders Equity of $163.00M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$824.50M
Net Income	$-365.90M
Cost of Goods Sold	$247.90M
Gross Profit	$576.60M
Operating Expenses	$1.21B
Operating Income	$-387.20M
Non-Operating Income/Expense	$-7.90M
Pre-Tax Income	$-395.10M
Normalized Pre-Tax Income	$-395.10M
Income after Taxes	$-365.90M
Income from Continuous Operations	$-365.90M
Consolidated Net Income/Loss	$-365.90M
Normalized Income after Taxes	$-365.90M
EBIT	$-387.20M
EBITDA	$-14.10M
Weighted-Average Shares Outstanding (Basic)	92.60M
Weighted-Average Shares Outstanding (Diluted)	92.60M
Earnings per Share (EPS) (Basic)	$-3.95
Earnings per Share (EPS) (Diluted)	$-3.95
Balance Sheet Financials
Current Assets	$332.60M
Property, Plant, and Equipment	$114.00M
Long-Term Assets	$374.00M
Total Assets	$706.60M
Current Liabilities	$133.80M
Long-Term Debt	$119.90M
Long-Term Liabilities	$204.80M
Total Liabilities	$338.60M
Common Equity	$368.00M
Tangible Shareholders Equity	$163.00M
Shareholders Equity	$368.00M
Common Shares Outstanding	93.50M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.80M
Cash Flow from Investing Activities	$-27.40M
Cash Flow from Financial Activities	$64.20M
Beginning Cash	$111.90M
End Cash	$151.30M
Increase/Decrease in Cash	$39.40M
Stock-Based Compensation	$35.20M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.49
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.25
Debt to Equity Ratio	0.33
Gross Margin	69.93%
Operating Margin	-46.96%
EBIT Margin	-46.96%
EBITDA Margin	-1.71%
Pre-Tax Profit Margin	-47.92%
Profit Margin	-44.38%
Free Cash Flow	$-13.80M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.17
Inventory Turnover	8.10
Receiveable Turnover	7.15
Days Sales in Receivables	51.04
Return on Equity	-99.43%
Return on Tangible Equity	-224.48%
Return on Assets	-51.78%
Return on Investments	-74.99%
Book Value Per Share	$3.94
Free Cash Flow per Share	$-0.15
Operating Cash Flow per Share	$0.02

Data from Zacks Investment Research, Inc.